1997
DOI: 10.1016/s0005-2760(97)00078-7
|View full text |Cite
|
Sign up to set email alerts
|

Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
54
0
1

Year Published

1999
1999
2014
2014

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 119 publications
(62 citation statements)
references
References 18 publications
7
54
0
1
Order By: Relevance
“…There is also clear evidence that in the mouse, AEA is synthesized in the kidney vasculature and acts both in the kidney and salivary gland to alter respective functioning [26]. However, in women AEA is not present in urine, in detectable enough quantities except during labour.…”
Section: Discussionmentioning
confidence: 99%
“…There is also clear evidence that in the mouse, AEA is synthesized in the kidney vasculature and acts both in the kidney and salivary gland to alter respective functioning [26]. However, in women AEA is not present in urine, in detectable enough quantities except during labour.…”
Section: Discussionmentioning
confidence: 99%
“…Levels of both AEA and 2-AG high enough to cause the activation of CB1 receptors have been measured in both rat and guinea pig MPLM (Katayama et al, 1997;Valenti et al, 2005;Guagnini et al, 2006). Alternatively, the augmentation of the twitch contractions may be through an unmasking of a constitutive activity of the CB1 receptor through inverse agonism (Pertwee, 2005).…”
Section: Cannabinoid Receptors In the Rat Ileum Mplm R Makwana Et Almentioning
confidence: 99%
“…In the rat ileum, the mRNAs of both cannabinoid receptors and their expression have been both identified and mapped in the myenteric plexus Valenti et al, 2005;Duncan et al, 2008). Furthermore, a number of endogenous cannabinoid ligands, exemplified by arachidonylethanolamide (AEA) and 2-arachidonylglycerol (2-AG), (Gomez et al, 2002;Mascolo et al, 2002;Izzo et al, 2003;Fegley et al, 2005;Valenti et al, 2005), along with the mechanisms for their enzymatic inactivation (Katayama et al, 1997), have been shown to be present in the rat ileum. Therefore, the purpose of this study was to investigate whether the rat ileum myenteric plexuslongitudinal muscle (MPLM) preparation served as a suitable and robust in vitro ileal cannabinoid receptor bioassay by assessing the interaction between representatives of the four main classes of cannabinoid receptor agonists, that is AEA, 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)-cy clohexyl]-phenol (CP 55,940), D 9 -tetrahydrocannabinol (D 9 -THC) and (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalen ylmethanone mesylate (WIN 55,, with the CB1 and CB2 receptor selective antagonist /inverse agonists rimonabant and SR 144 528 respectively.…”
Section: Introductionmentioning
confidence: 99%
“…It is now considered that these enzymes are the same membrane-bound protein. The enzyme is widely distributed in mammalian organs (28,30,31) and characterized by an optimal pH value at 8.5-10 (9, 29) and by high sensitivity to phenylmethylsulfonyl fluoride (27) and methyl arachidonyl fluorophosphonate (MAFP) 1 (32,33). The enzyme has a broad substrate specificity but hydrolyzes N-palmitoylethanolamine at a lower rate than anandamide (9,28,29,34,35).…”
mentioning
confidence: 99%